Company intelligence / Profile preview

Swiss Stem Cells Biotech

Zürich, Zurich, Switzerland
Ownership
Private
Employees
~25
Development stage
Other
01

Overview

Swiss Stem Cells Biotech operates a FACT‑NetCord–accredited, GMP‑certified private/hybrid biobank in Switzerland that has stored over 26,000 samples, has released family cord blood units and >400 mesenchymal stem cell preparations (SVF) for clinical use, and functions as an ATMP‑grade manufacturing and storage facility for cord blood, cord tissue, placental tissue, adipose‑derived stem cells, and immune cells.

Therapeutic areas
HematologyImmunologyNeurologyRheumatologyRare DiseasesOncology
Modalities
Stem cell therapyCell therapy
Industry
Contract Manufacturing Organization
02

Partnerships

Swiss Federal Office of Public Health (FOPH) – public‑private hybrid cord blood banking pilot projectWomen’s Clinic of Inselspital Bern – hybrid banking collaborationBlood Transfusion Service of the Swiss Red Cross (SRC) – hybrid banking collaborationWorld Marrow Donor Association (WMDA) – collaboration as a hybrid bankSwiss Stem Cell Foundation (within Swiss Stem Cells Solutions network)Numerous Swiss clinics via Swiss Stem Cells Solutions networkComecer – supplier of modular cell culture isolators for SSCB laboratory

Beyond the preview

Go deeper on Swiss Stem Cells Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Swiss Stem Cells Biotech.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call